IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
The principal aim of IN VIVO is to provide for the prompt publication of accepted articles, generally within 1-2 months from final acceptance.
IN VIVO supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
Publication Data
IN VIVO appears bimonthly online-only and open access through the Stanford University Highwire Press. Each annual volume contains six issues and index.
Articles in IN VIVO are regulary indexed in bibliographic services, including PubMed, Index Medicus, MEDLINE, Biological Abstracts, BIOSIS, PREVIEWS, Science Citation Index Expanded (Web of Science), Chemical Abstracts, Excerpta Medica, CANCER-LIT Database, University of Sheffield Biomedical Information Service (SUBIS), Current Clinical Cancer, AIDS Abstracts, Progress in Paliative Care, Update-Research Information Systems Inc., Inpharma-Reactions Datastar, BRS), Reference Update (I.S.I.), Research Alert (I.S.I.), BioBase, MedBase, Investigational Drugs Database, Sociedad Iberoamericana de Información Científica (SIIC Data Bases).